News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Perrigo’s Partner Syntho Pharmaceutical Receives FDA Tentative Approval for Levocetirizine Solution - Generic Equivalent to Xyzal(R) Oral Solution
May 18, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
FDA
Krystal Biotech’s FDA Platform Designation Pushes Limits of the Award
October 21, 2025
·
2 min read
·
Dan Samorodnitsky
Lung cancer
Summit Eyes 2025 FDA Application for Ivonescimab Despite Overall Survival Miss
October 21, 2025
·
2 min read
·
Tristan Manalac
Autoimmune disease
Roche’s Gazyva Expands Out of Cancer With FDA Approval for Lupus
October 20, 2025
·
2 min read
·
Dan Samorodnitsky
FDA
Replimune Soars Upon FDA Resubmission for Advanced Melanoma Drug
October 20, 2025
·
2 min read
·
Heather McKenzie